Opioids, Reward and Addiction: An Encounter of Biology ...

Martin TJ, Smith JE and Dworkin SI (1998) Training dose and session time as
contextual determinants of heroin self-administration in rats. Pharmacol Biochem
Behav 60:415–421.
Martin WR, Eades CG, Thompson JA, Huppler RE and Gilbert PE (1976) The effects
of morphine- and nalorphine- like drugs in the nondependent and morphinedependent
chronic spinal dog. J Pharmacol Exp Ther 197:517–532.
Mason BJ, Ritvo EC, Salvato F, Zimmer E, Goldberg G and Welch B (1993) Preliminary
dose finding studies for nalmefene treatment of alcoholism. Alcohol Clin Exp
Res 18:464.
Mason BJ, Ritvo EC, Morgan RO, Salvato FR, Goldberg G, Welch B and Mantero-
Atienza E (1994) A double-blind, placebo-controlled pilot study to evaluate the
efficacy and safety of oral nalmefene HCl for alcohol dependence. Alcohol Clin Exp
Res 18:1162–1167.
Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K,
Dierich A, Le Meur M, Dolle P, Tzavara E, Hanoune J, Roques BP and Kieffer BL
(1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms
in mice lacking the -opioid-receptor gene. Nature (Lond) 383:819–823.
Mattox AJ and Carroll ME (1996) Smoked heroin self-administration in rhesus
monkeys. Psychopharmacology 125:195–201.
McMillan DE and Leander JD (1976) Schedule-induced oral self administration of
etonitazene. Pharmacol Biochem Behav 4:137–141.
Meisch RA and Stark LJ (1977) Establishment of etonitazene as a reinforcer for rats
by the use of schedule-induced drinking. Pharmacol Biochem Behav 2:589–836.
Mello NK, Bree MP and Mendelson JH (1983) Comparison of buprenorphine and
methadone effects on opiate self-administration in primates. J Pharmacol Exp
Ther 225:378–386.
Mello NK, Kamien JB, Lukas SE, Drieze J and Mendelson JH (1993a) The effects of
nalbuphine and butorphanol treatment on cocaine and food self-administration by
rhesus monkeys. Neuropsychopharmacology 8:45–55.
Mello NK, Kamien JB, Lukas SE, Mendelson JH, Drieze JM and Sholar JW (1993b)
Effects of intermittent buprenorphine administration on cocaine self-administration
by rhesus monkeys. J Pharmacol Exp Ther 264:530–541.
Mello NK, Lukas SE, Kamien JB, Mendelson JH, Drieze J and Cone EJ (1992) The
effects of chronic buprenorphine treatment on cocaine and food self-administration
by rhesus monkeys. J Pharmacol Exp Ther 260:1185–1193.
Mello NK, Lukas SE, Mendelson JH and Drieze J (1993c) Naltrexone-buprenorphine
interactions: Effects on cocaine self-administration. Neuropsychopharmacology
9:221–224.
Mello NK and Mendelson JH (1978) Self-administration of an enkephalin analog by
rhesus monkey. Pharmacol Biochem Behav 9:579–586.
Mello NK and Mendelson JH (1979) Effects of the neuropeptide DG-AVP on morphine
and food self-administration by dependent rhesus monkey. Pharmacol Biochem
Behav 10:415–419.
Mello NK, Mendelson JH, Bree MP and Lukas SE (1989) Buprenorphine suppresses
cocaine self-administration by rhesus monkeys. Science (Wash DC) 245:859–862.
Mello NK, Mendelson JH, Bree MP and Lukas SE (1990) Buprenorphine and naltrexone
effects on cocaine self-administration by rhesus monkeys. J Pharmacol
Exp Ther 254:926–939.
Mello NK and Negus SS (1996) Preclinical evaluation of pharmacotherapies for
treatment of cocaine and opioid abuse using drug self-administration procedures
Neuropsychopharmacology 14:375–424.
Mendelson J, Jones RT, Fernandez I, Welm S, Melby AK and Baggott MJ (1996)
Buprenorphine and naloxone interactions in opiate-dependent volunteers. Clin
Pharmacol Ther 60:105–114.
Mendelson J, Jones RT, Welm S, Brown J and Batki SL (1997) Buprenorphine and
naloxone interactions in methadone maintenance patients. Biol Psychiatry 41:
1095–1101.
Menkens K, Bilsky EJ, Wild KD, Portoghese PS, Reid LD and Porreca F (1992)
Cocaine place preference is blocked by the -opioid receptor antagonist, naltrindole.
Eur J Pharmacol 219:345–346.
Meunier J-C, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour JL,
Guillemot J-C, Ferrara P, Monsarrat B, Mazarguil H, Vassart G, Parmentier M
and Costentin J (1995) Isolation and structure of the endogenous agonist of opioid
receptor-like ORL1 receptor. Nature (Lond) 377:532–535.
Mocchetti I, Ritter A and Costa E (1989) Down-regulation of proopiomelanocortin
synthesis and -endorphin utilization in hypothalamus of morphine-tolerant rats.
J Mol Neurosci 1:33–38.
Mogenson GJ and Wu M (1982) Neuropharmacological and electrophysiological
evidence implicating the mesolimbic dopamine system in feeding responses elicited
by electrical stimulation of the medial forebrain bundle. Brain Res 253:243–
251.
Moldow RL and Fischman AJ (1987) Cocaine induced secretion of ACTH, -endorphin,
and corticosterone. Peptides 8:819–822.
Mollereau C, Parmentier M, Mailleux P, Butour J-L, Moisnad C, Chalon P, Caput D,
Vassart G and Meunier J-C (1994) ORL1, a novel member of the opioid receptor
family: cloning, functional expression and localization. FEBS Lett 341:33–38.
Moolten M and Kornetsky C (1990) Oral self-administration of ethanol and not
experimenter-administered ethanol facilitates rewarding electrical brain stimulation.
Alcohol 7:221–225.
Morris RGM, Anderson E, Lynch GS and Baudry M (1986) Selective impairment of
learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor
antagonist, AP5. Nature (Lond) 319:774–776.
Mosner A, Kuhlman G, Roehm C and Vogel WH (1997) Serotonergic receptors modify
the voluntary intake of alcohol and morphine but not of cocaine and nicotine by
rats. Pharmacology 54:186–192.
Mucha RF (1987) Is the motivational effect of opiate withdrawal reflected by common
somatic indices of precipitated withdrawal? A place conditioning study in the rat.
Brain Res 418:214–220
Mucha RF and Herz A (1985) Motivational properties of - and -opioid receptor
agonists studied with place and taste preference conditioning. Psychopharmacology
86:274–280.
OPIOIDS, REWARD AND ADDICTION 391
Mucha RF and Herz A (1986) Preference conditioning produced by opioid active and
inactive isomers of levorphanol and morphine in rat. Life Sci 38:241–249.
Mucha RF and Iversen SD (1984) Reinforcing properties of morphine and naloxone
revealed by conditioned place preferences: A procedural examination. Psychopharmacology
82:241–247.
Mucha RF, Millan MJ and Herz A (1985) Aversive properties of naloxone in nondependent
(naive) rats may involve blockade of central -endorphin. Psychopharmacology
86:281–285.
Mucha RF, Van der Kooy D, O’Shaughnessy M and Bucenieks P (1982) Drug
reinforcement studied by the use of place conditioning in rat. Brain Res 243:91–
105.
Mucha RF and Walker MJ (1987) Aversive property of opioid receptor blockade in
drug-naive mice. Psychopharmacology 93:483–488.
Myers RD and Lankford MF (1996) Suppression of alcohol preference in high alcohol
drinking rats: Efficacy of amperozide versus naltrexone. Neuropsychopharmacology
14:139–149.
Nader K, Bechara A, Roberts DC and Van der Kooy D (1994) Neuroleptics block highbut
not low-dose heroin place preferences: further evidence for a two-system model
of motivation. Behav Neurosci 108:1128–1138.
Nader K, Bechara A and Van der Kooy D (1997) Neurobiological constraints on
behavioral models of motivation. Annu Rev Psychol 48:85–114.
Nader K and Van der Kooy D (1996) Clonidine antagonizes the aversive effects of
opiate withdrawal and the rewarding effects of morphine only in opiate withdrawn
rats. Behav Neurosci 110:389–400.
Nader K and Van der Kooy D (1997) Deprivation state switches the neurobiological
substrates mediating opiate reward in the ventral tegmental area. J Neurosci
17:383–390.
Nakahara D, Fuchikami K, Ozaki N, Iwasaki T and Nagatsu T (1992) Differential
effect of self-stimulation on dopamine release and metabolism in the rat medial
frontal cortex, nucleus accumbens and striatum studied by in vivo microdialysis.
Brain Res 574:164–170.
Nakajima S and Wise RA (1987) Heroin self-administration in the rat suppressed by
SCH23390. Soc Neuroscience Abst 13:1545.
Nakanishi S, Inoue A, Kita T, Nakamra M, Chang AC, Cohen SN and Numa S (1979)
Nucleotide sequence of cloned cDNA for bovine corticotropin--lipotropin precursor.
Nature (Lond) 278:423–427.
Narita M and Tseng LF (1998) Evidence for the existence of the beta-endorphinsensitive
“epsilon- opioid receptor” in the brain: The mechanisms of epsilonmediated
antinociception. Jpn J Pharmacol 76:233–253.
Nazzaro JM, Seeger TF and Gardner EL (1981) Morphine differentially affects
ventral tegmental and substantia nigra brain reward thresholds. Pharmacol Biochem
Behav 14:325–331.
Negus SS, Henriksen SJ, Mattox A, Pasternak GW, Portoghese PS, Takemori AE,
Weinger MB and Koob GF (1993) Effect of antagonists selective for -, - and
-opioid receptors on the reinforcing effects of heroin in rats. J Pharmacol Exp
Ther 265:1245–1252.
Negus SS, Mello NK, Portoghese PS and Lin CE (1997) Effects of -opioids on cocaine
self-administration by rhesus monkeys. J Pharmacol Exp Ther 282:44–55.
Negus SS, Mello NK, Portoghese PS, Lukas SE and Mendelson JH (1995) Role of
-opioid receptors in the reinforcing and discriminative stimulus effects of cocaine
in rhesus monkeys. J Pharmacol Exp Ther 273:1245–1256.
Neisewander JL, Pierce RC and Bardo MT (1990) Naloxone enhances the expression
of morphine-induced conditioned place preference. Psychopharmacology 100:201–
205.
Nelson WT Jr, Steiner SS, Brutus M, Farrell R and Ellman SJ (1981) Brain site
variations in effects of morphine on electrical self-stimulation. Psychopharmacology
74:58–65.
Nestby P, Schoffelmeer ANM, Homberg JR, De Vries TJ, Mulder AH and Vanderschuren
LJMJ (1999) Bremazocine reduces unrestricted free-choice ethanol selfadministration
in rats without affecting sucrose preference. Psychopharmacology
142:309–317.
Noble F, Fournie Zaluski MC and Roques BP (1993) Unlike morphine the endogenous
enkephalins protected by RB101 are unable to establish a conditioned place
preference in mice. Eur J Pharmacol 230:139–149.
Noda M, Furutani Y, Takahashi H, Toyosato M, Hirose T, Inayama S, Nakanishi S
and Numa S (1982) Cloning and sequence analysis of cDNA for bovine adrenal
preproenkephalin. Nature (Lond) 295:202–206.
Nomikos GG and Spyraki C (1988) Effects of ritanserin on the rewarding properties
of -amphetamine, morphine and diazepam revealed by conditioned place preference
in rats. Pharmacol Biochem Behav 30:853–858.
Nylander I, Hyyti P, Forsander O and Terenius L (1994) Differences between
alcohol-preferring (AA) and alcohol-avoiding (ANA) rats in the prodynorphin and
proenkephalin systems. Alcohol Clin Exp Res 18:1272–1279.
O’Brien CP (1996) Drug addiction and drug abuse, in Goodman and Gilman’s The
Pharmacological Basis of Therapeutics (Hardman J and Limbird L eds) pp 557–
577, McGraw-Hill, New York.
O’Brien CP (1997) A range of research-based pharmacotherapies for addiction.
Science (Wash DC) 278:66–70.
O’Brien CP, Chaddock B, Woody G and Greenstein R (1974) Systematic extinction of
narcotic drug use using narcotic antagonists. Psychosom Med 36:458.
O’Brien CP, Testa T, O’Brien TJ, Brady JP and Wells B (1977) Conditioned narcotic
withdrawal in humans. Science (Wash DC) 195:1000–1002.
O’Connor JJ, Moloney E, Travers R and Campbell A (1988) Buprenorphine abuse
among opiate addicts. Br J Addict 83:1085–1087.
O’Malley SS (1995) Integration of opioid antagonists and psychosocial therapy in the
treatment of narcotic and alcohol dependence. J Clin Psychiatry 56 (Suppl 7):30–
38.
O’Malley SS, Adam JJ, Chang G, Schottenfeld R, Meyer RE and Rounsaville B (1992)
Naltrexone and coping skills therapy for alcohol dependence. Arch Gen Psychiatry
49:881–887.
O’Malley SS, Jaffe AJ, Rode S and Rounsaville BJ (1996) Experience of a “slip”